-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Taro Pharmaceutical Industries Ltd quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2012 to Q1 2023.
- Taro Pharmaceutical Industries Ltd Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending March 31, 2023 was $18.5M, a 50.7% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)